இணைக்கப்பட்டுள்ளது மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana
How 1 hospital successfully adapted to thrive during COVID-19
healthcaredive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthcaredive.com Daily Mail and Mail on Sunday newspapers.
How one hospital successfully adapted to thrive during COVID-19
healthcaredive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthcaredive.com Daily Mail and Mail on Sunday newspapers.
Apr 1, 2021 12:02pm
Phenomix Sciences blood-based test uses phenotype-driven multi-omics technology to predict responses to obesity interventions the Food and Drug Administration has approved. (vadimguzhva/GettyImages)
The American Medical Association innovation subsidiary Health2047 has spun off a company that uses personalized medicine to fight obesity.
Phenomix Sciences is a phenotype testing company that carries out the AMA’s mission to confront chronic diseases such as obesity.
Phenomix uses a blood test called MyPhenome that it has licensed from the Mayo Clinic to allow doctors to prescribe individualized therapies. MyPhenome measures DNA as well as a person’s metabolites and hormones. These biomarkers make up a person’s phenotype, according to Phenomix.
MedCity News
A look at the diagnostics chapter of precision medicine
More than 80% of representatives of health systems have established genomic data management strategies or plan to do so within the next couple of years.
Shares0
Diagnostics are a critical part of precision medicine. They can be used to screen patients for breakthrough therapies, detect certain conditions, especially cancer, earlier. But this area of medical innovation is balanced between promising new developments in molecular diagnostics, genetic testing and liquid biopsies, the delivery of these tests, and the all important question of who pays for it.
More than 80% of representatives of health systems have established genomic data management strategies or plan to do so within the next couple of years, according to a report by University of Pittsburgh Medical Center’s Center for Connected Medicine and HIMSS Media, which surveyed 101 health system and hospital representatives in the U.S. The report indicat